Leef Brands (LEEEF) Operating Leases (2023 - 2026)

Leef Brands (LEEEF) posted Operating Leases of $1.6 million for Q1 2026, down 2.93% sequentially from $1.7 million in Q4 2025.

Leef Brands (LEEEF) Operating Leases (2023 - 2026) Analysis & Trends

Leef Brands has reported Operating Leases for 4 years, with the latest figure at $1.6 million in Q1 2026.

Quarterly Operating Leases changed N/A year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (changed N/A YoY) and the FY2025 annual result came in at $1.7 million, down 27.32% from the prior year.
Operating Leases fell to $1.6 million in Q1 2026 per LEEEF's latest filing, from $1.7 million in the prior quarter.
Over five years, Operating Leases peaked at $2.3 million in Q4 2023 and troughed at $1.6 million in Q1 2026.
A 4-year average of $2.0 million and a median of $2.0 million in 2024 frame the typical range for Operating Leases.
The sharpest annual moves came in 2024 and 2025: Operating Leases decreased 2.85% in 2024, then slipped 27.32% in 2025.
Over 4 years, Operating Leases stood at $2.3 million in 2023, then dropped by 2.85% to $2.3 million in 2024, then retreated by 27.32% to $1.7 million in 2025, then slipped by 2.93% to $1.6 million in 2026.
According to Business Quant data, Operating Leases over the past three periods registered $1.6 million, $1.7 million, and $2.3 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	Leef Brands	59.45 Mn	54.50 Mn	2.41 Mn

Download Data